LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | JW-7-24-1 | 3.33 | uM | LJP6 | 3 | B20 | 72 | hr | 1235 | 2921 | 4583 | 0.6373 | 0.5760 |
MDA-MB-231 | JW-7-24-1 | 10 | uM | LJP6 | 1 | B19 | 72 | hr | 1235 | 624 | 4355 | 0.1433 | -0.3134 |
MDA-MB-231 | JW-7-24-1 | 10 | uM | LJP6 | 2 | B19 | 72 | hr | 1235 | 487 | 4277 | 0.1139 | -0.4055 |
MDA-MB-231 | JW-7-24-1 | 10 | uM | LJP6 | 3 | B19 | 72 | hr | 1235 | 786 | 4583 | 0.1715 | -0.2129 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP6 | 1 | I06 | 72 | hr | 1235 | 785 | 4355 | 0.1802 | -0.2210 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP6 | 2 | I06 | 72 | hr | 1235 | 799 | 4277 | 0.1868 | -0.2162 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP6 | 3 | I06 | 72 | hr | 1235 | 837 | 4583 | 0.1826 | -0.1863 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP5 | 1 | D06 | 72 | hr | 1235 | 2709 | 4474 | 0.6054 | 0.5262 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP5 | 2 | D06 | 72 | hr | 1235 | 2660 | 4578 | 0.5810 | 0.5004 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP5 | 3 | D06 | 72 | hr | 1235 | 2704 | 4929 | 0.5486 | 0.4804 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP6 | 1 | I05 | 72 | hr | 1235 | 810 | 4355 | 0.1860 | -0.2075 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP6 | 2 | I05 | 72 | hr | 1235 | 784 | 4277 | 0.1833 | -0.2244 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP6 | 3 | I05 | 72 | hr | 1235 | 810 | 4583 | 0.1767 | -0.2003 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP5 | 1 | D05 | 72 | hr | 1235 | 1297 | 4474 | 0.2899 | 0.0263 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP5 | 2 | D05 | 72 | hr | 1235 | 1366 | 4578 | 0.2984 | 0.0544 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP5 | 3 | D05 | 72 | hr | 1235 | 1374 | 4929 | 0.2787 | 0.0545 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP6 | 1 | I04 | 72 | hr | 1235 | 777 | 4355 | 0.1784 | -0.2254 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP6 | 2 | I04 | 72 | hr | 1235 | 756 | 4277 | 0.1767 | -0.2400 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP6 | 3 | I04 | 72 | hr | 1235 | 781 | 4583 | 0.1704 | -0.2156 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP5 | 1 | D04 | 72 | hr | 1235 | 819 | 4474 | 0.1830 | -0.1988 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP5 | 2 | D04 | 72 | hr | 1235 | 704 | 4578 | 0.1538 | -0.2576 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP5 | 3 | D04 | 72 | hr | 1235 | 848 | 4929 | 0.1720 | -0.1720 |
MDA-MB-231 | Dasatinib | 1.11 | uM | LJP6 | 1 | I03 | 72 | hr | 1235 | 755 | 4355 | 0.1733 | -0.2375 |
MDA-MB-231 | Dasatinib | 1.11 | uM | LJP6 | 2 | I03 | 72 | hr | 1235 | 488 | 4277 | 0.1141 | -0.4048 |
MDA-MB-231 | Dasatinib | 1.11 | uM | LJP6 | 3 | I03 | 72 | hr | 1235 | 742 | 4583 | 0.1619 | -0.2365 |